Cancer metastasis - tricks of the trade

Rabia Zeeshan1, Zeeshan Mutahir

  • 1Interdisciplinary Research Centre in Biomedical Materials, COMSATS Institute of Information Technology, Lahore, Pakistan. rabiazeeshan@ciitlahore.edu.pk.

Insights

Cancer metastasis involves sequential steps influenced by genetic and epigenetic factors. Understanding these processes is key to developing targeted therapies for better patient outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Metastatic tumors are a leading cause of cancer-related deaths globally.
  • Cancer metastasis is a complex, multi-step process.
  • Genetic and epigenetic heterogeneity plays a crucial role in metastasis.

Purpose of the Study:

  • To review the sequential events of cancer metastasis.
  • To highlight the influence of genetic and epigenetic heterogeneity on metastasis.
  • To discuss the factors contributing to the severity and site of metastasis.

Main Methods:

  • Literature review of cancer metastasis.
  • Analysis of genetic and epigenetic influences on metastatic pathways.
  • Examination of the tumor microenvironment and cancer stem cells (CSCs) in metastasis.

Main Results:

  • Metastasis involves invasion, intravasation, survival in circulation, extravasation, and colonization.
  • Heterogeneity in tumor microenvironment, CSCs, and immune support impacts each step.
  • Regulation of pro-metastatic and evasion of anti-metastatic mechanisms dictate metastatic outcome.

Conclusions:

  • A comprehensive understanding of tumor cell fate and metastatic mechanisms is essential.
  • Targeted cancer therapies can be designed based on a deeper insight into metastasis.
  • Future research should focus on individual tumor cell behavior and promoting factors.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.2K